
Rapamycin-D3CAS 392711-19-2
- Catalogue No.
- CSL-45259
- CAS No.
- 392711-19-2
- Molecular formula
- C51H76D3NO13
- Molecular weight
- 917.19
- Parent drug
- rapamycin, sirolimus
- Product type
- Impurities, Pharmaceutical Reference Standards, Intermediates and building blocks, pharmaceutical standards, Fine Chemicals, Stable isotope labelled, Heterocycles, Chiral standards, enzyme inhibitors
Quick quote · CSL-45259Price and availability on request
ISO 17034:2016 · GLPTell us the quantity you need, from a few milligrams upwards, and we reply within 24 hours with price, availability and delivery time.
Need documents or a larger lot? Use the full quote form
Synonyms
- (-)-Rapamycin-d3
- AY 22989-d3
- Antibiotic AY 22989-d3
Show all 14 synonyms
- Cypher-d3
- NSC 226080-d3
- RAPA-d3
- RPM-d3
- Rapammune-d3
- Rapamune-d3
- SIIA 9268A-d3
- Sirolimus-d3
- Wy 090217-d3
- Rapamycin-d3 (Sirolimus-d3, Everolimus EP Impurity A-d3)
- Rapamycin-d3 (contains d0) Technical Grade
More rapamycin products
All 67 →![Chemical structure of (19E/Z)-seco-[4-O-[2-Hydroxy(ethyl)-d4]] Rapamycin Sodium Salt](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F19EZ-seco-4-O-2-Hydroxyethyl-d4-Rapamycin-Sodium-Salt.png&w=3840&q=75)
(19E/Z)-seco-[4-O-[2-Hydroxy(ethyl)-d4]] Rapamycin Sodium SaltCSL-177150
![Chemical structure of (3R,9aS)-3-Hydroxy-3-((2R,3R,6S)-2-hydroxy-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxodocosa-3,5,7,15,19-pentaen-1-yl)-3-methyltetrahydro-2H-pyran-2-yl)tetrahydropyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3R9aS-3-Hydroxy-3-2R3R6S-2-hydroxy-6-2S3E5E7E9S11R13R14R15E17R19E21R-14-hydroxy-22-1S3R4R-4-hydroxy-3-methoxycyclohexyl-213-dimethoxy-3911151721-hexam.png&w=3840&q=75)
(3R,9aS)-3-Hydroxy-3-((2R,3R,6S)-2-hydroxy-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxodocosa-3,5,7,15,19-pentaen-1-yl)-3-methyltetrahydro-2H-pyran-2-yl)tetrahydropyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dioneCSL-192692

(7R)-Rapamycin157182-37-1
![Chemical structure of (9aS)-3-Hydroxy-3-((2R,3R,6S)-2-hydroxy-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E)-14-hydroxy-2,13-dimethoxy-3,9,11,15-tetramethyl-12,17-dioxooctadeca-3,5,7,15-tetraen-1-yl)-3-methyltetrahydro-2H-pyran-2-yl)tetrahydropyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F9aS-3-Hydroxy-3-2R3R6S-2-hydroxy-6-2S3E5E7E9S11R13R14R15E-14-hydroxy-213-dimethoxy-391115-tetramethyl-1217-dioxooctadeca-35715-tetraen-1-yl-3-methylte.png&w=3840&q=75)
(9aS)-3-Hydroxy-3-((2R,3R,6S)-2-hydroxy-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E)-14-hydroxy-2,13-dimethoxy-3,9,11,15-tetramethyl-12,17-dioxooctadeca-3,5,7,15-tetraen-1-yl)-3-methyltetrahydro-2H-pyran-2-yl)tetrahydropyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dioneCSL-193984

